These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 29319498)

  • 1. Safety and tolerance of cidofovir as a 2% gel for local application in high-grade cervical intraepithelial neoplasia: A phase 1 investigation.
    Bossens M; Jost M; Van Pachterbeke C; De Maertelaer V; Simon P; Frankenne F; Hubert P; Evrard B; Snoeck R
    Int J Clin Pharmacol Ther; 2018 Mar; 56(3):134-141. PubMed ID: 29319498
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Topical treatment of CIN 2+ by cidofovir: results of a phase II, double-blind, prospective, placebo-controlled study.
    Van Pachterbeke C; Bucella D; Rozenberg S; Manigart Y; Gilles C; Larsimont D; Vanden Houte K; Reynders M; Snoeck R; Bossens M
    Gynecol Oncol; 2009 Oct; 115(1):69-74. PubMed ID: 19647859
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activity, safety, and feasibility of cidofovir and imiquimod for treatment of vulval intraepithelial neoplasia (RT³VIN): a multicentre, open-label, randomised, phase 2 trial.
    Tristram A; Hurt CN; Madden T; Powell N; Man S; Hibbitts S; Dutton P; Jones S; Nordin AJ; Naik R; Fiander A; Griffiths G
    Lancet Oncol; 2014 Nov; 15(12):1361-8. PubMed ID: 25304851
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics and safety of intravesicular cidofovir in allogeneic HSCT recipients.
    Aitken SL; Zhou J; Ghantoji SS; Kontoyiannis DP; Jones RB; Tam VH; Chemaly RF
    J Antimicrob Chemother; 2016 Mar; 71(3):727-30. PubMed ID: 26612873
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cidofovir, a new approach for the treatment of cervix intraepithelial neoplasia grade III (CIN III).
    Snoeck R; Noel JC; Muller C; De Clercq E; Bossens M
    J Med Virol; 2000 Feb; 60(2):205-9. PubMed ID: 10596022
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety and efficacy of topical cidofovir to treat high-grade perianal and vulvar intraepithelial neoplasia in HIV-positive men and women.
    Stier EA; Goldstone SE; Einstein MH; Jay N; Berry JM; Wilkin T; Lee JY; Darragh TM; Da Costa M; Panther L; Aboulafia D; Palefsky JM
    AIDS; 2013 Feb; 27(4):545-51. PubMed ID: 23032420
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics and renal effects of cidofovir with a reduced dose of probenecid in HIV-infected patients with cytomegalovirus retinitis.
    Wolf DL; Rodríguez CA; Mucci M; Ingrosso A; Duncan BA; Nickens DJ
    J Clin Pharmacol; 2003 Jan; 43(1):43-51. PubMed ID: 12520627
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Successful treatment of periungual warts with topical cidofovir.
    Padilla España L; Del Boz J; Fernández Morano T; Arenas-Villafranca J; de Troya M
    Dermatol Ther; 2014; 27(6):337-42. PubMed ID: 25081902
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase I trial evaluating the antiviral agent Cidofovir in combination with chemoradiation in cervical cancer patients.
    Deutsch E; Haie-Meder C; Bayar MA; Mondini M; Laporte M; Mazeron R; Adam J; Varga A; Vassal G; Magné N; Chargari C; Lanoy E; Pautier P; Levy A; Soria JC
    Oncotarget; 2016 May; 7(18):25549-57. PubMed ID: 27016411
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical responses to Cidofovir applied topically to women with high grade vulval intraepithelial neoplasia.
    Tristram A; Fiander A
    Gynecol Oncol; 2005 Dec; 99(3):652-5. PubMed ID: 16169066
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Successful treatment of recurrent vulvar intraepithelial neoplasia resistant to interferon and isotretinoin with cidofovir.
    Koonsaeng S; Verschraegen C; Freedman R; Bossens M; Kudelka A; Kavanagh J; Sittisomwong T; DeClercq E; Snoeck R
    J Med Virol; 2001 Jun; 64(2):195-8. PubMed ID: 11360253
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Topical cidofovir-induced acute kidney injury in two severely immunocompromised patients with refractory multidrug-resistant herpes simplex virus infections.
    Saunders IM; Lahoti A; Chemaly RF; Trevino C; Westmoreland M; Hosing C
    J Oncol Pharm Pract; 2016 Apr; 22(2):325-31. PubMed ID: 25488905
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Topical use of cidofovir induced acute renal failure.
    Bienvenu B; Martinez F; Devergie A; Rybojad M; Rivet J; Bellenger P; Morel P; Gluckman E; Lebbé C
    Transplantation; 2002 Feb; 73(4):661-2. PubMed ID: 11889450
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urrets-Zavalia syndrome as a complication of ocular hypotonia due to intravenous cidofovir treatment.
    Orssaud C; Wermert D; Roux A; Laccourreye O; Sors H; Roche O; Dufier JL
    Eye (Lond); 2014 Jun; 28(6):776-7. PubMed ID: 24675584
    [No Abstract]   [Full Text] [Related]  

  • 15. [Treatment of cutaneous human papilloma virus, poxvirus and herpes simplex virus infections with topical cidofovir in HIV positive patients].
    Toutous-Trellu L; Hirschel B; Piguet V; Schiffer V; Saurat JH; Pechère M
    Ann Dermatol Venereol; 2004 May; 131(5):445-9. PubMed ID: 15235531
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Safety and tolerability of cidofovir in high-risk pediatric patients.
    Bhadri VA; Lee-Horn L; Shaw PJ
    Transpl Infect Dis; 2009 Aug; 11(4):373-9. PubMed ID: 19392729
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Topical cidofovir to treat high-grade anal intraepithelial neoplasia in HIV-infected patients: a pilot clinical trial.
    Sendagorta E; Bernardino JI; Álvarez-Gallego M; Feíto M; Feltes R; Beato MJ; Pérez-Molina JA; Yllescas M; Díaz-Almirón M; Arribas JR; González-García J; Herranz P;
    AIDS; 2016 Jan; 30(1):75-82. PubMed ID: 26731755
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic paint of cidofovir/sucralfate gel combination topically administered by spraying for treatment of orf virus infections.
    Sonvico F; Colombo G; Gallina L; Bortolotti F; Rossi A; McInnes CJ; Massimo G; Colombo P; Scagliarini A
    AAPS J; 2009 Jun; 11(2):242-9. PubMed ID: 19381838
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of recurrent respiratory papillomatosis and adverse reactions following off-label use of cidofovir (Vistide®).
    Tjon Pian Gi RE; Dietz A; Djukic V; Eckel HE; Friedrich G; Golusinski W; Hantzakos A; Lawson G; Remacle M; Rihkanen H; Dikkers FG
    Eur Arch Otorhinolaryngol; 2012 Feb; 269(2):361-2. PubMed ID: 22020697
    [No Abstract]   [Full Text] [Related]  

  • 20. Intravenous cidofovir for peripheral cytomegalovirus retinitis in patients with AIDS. A randomized, controlled trial.
    Lalezari JP; Stagg RJ; Kuppermann BD; Holland GN; Kramer F; Ives DV; Youle M; Robinson MR; Drew WL; Jaffe HS
    Ann Intern Med; 1997 Feb; 126(4):257-63. PubMed ID: 9036797
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.